Compounds > sb 203580
Page last updated: 2024-09-05

sb 203580 and dichlororibofuranosylbenzimidazole

sb 203580 has been researched along with dichlororibofuranosylbenzimidazole in 3 studies

Compound Research Comparison

Studies
(sb 203580)		Trials
(sb 203580)		Recent Studies (post-2010)
(sb 203580)		Studies
(dichlororibofuranosylbenzimidazole)		Trials
(dichlororibofuranosylbenzimidazole)		Recent Studies (post-2010) (dichlororibofuranosylbenzimidazole)
3,48941,137528264

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)dichlororibofuranosylbenzimidazole (IC50)
Chain A, Cell division protein kinase 9Homo sapiens (human)34.29
Chain A, Cell division protein kinase 2Homo sapiens (human)34.29

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1
Anderson, A; Atfi, A; Gilot, D; Guillouzo, A; Joannard, F; Lagadic-Gossmann, D; Orfila-Lefeuvre, L; Rissel, M1
Derebecka-Holysz, N; Holysz, M; Lehmann, TP; Trzeciak, WH1

Other Studies

3 other study(ies) available for sb 203580 and dichlororibofuranosylbenzimidazole

ArticleYear
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007
Role for mitogen-activated protein kinases in phenobarbital-induced expression of cytochrome P450 2B in primary cultures of rat hepatocytes.
    Toxicology letters, 2006, Feb-08, Volume: 161, Issue:1

    Topics: Animals; Blotting, Northern; Butadienes; Cells, Cultured; Cytochrome P-450 CYP2B1; Dichlororibofuranosylbenzimidazole; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Enzyme Inhibitors; Gene Expression; Hepatocytes; Imidazoles; Luciferases, Firefly; Male; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Mutation; Nitriles; p38 Mitogen-Activated Protein Kinases; Phenobarbital; Phosphorylation; Pyridines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transfection

2006
TGF-beta inhibits CYP17 transcription in H295R cells acting via activin receptor-like kinase 5.
    Endocrine research, 2009, Volume: 34, Issue:3

    Topics: Activin Receptors; Adrenal Cortex; Benzamides; Cell Line; Colforsin; Cytochromes b5; Dichlororibofuranosylbenzimidazole; Dioxoles; Humans; Imidazoles; MAP Kinase Kinase 1; NADPH-Ferrihemoprotein Reductase; p38 Mitogen-Activated Protein Kinases; Protein Serine-Threonine Kinases; Pyridines; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; RNA, Messenger; Steroid 17-alpha-Hydroxylase; Transforming Growth Factor beta

2009